Carlisle Companies Incorporated (CSL)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 1,634,200 1,570,000 1,618,400 1,561,500 1,535,300 1,333,500 994,400 713,900 538,400 476,000 463,100 443,100 453,100 670,500 888,200 1,162,600 1,371,700 1,341,800 1,275,900 1,213,900
Revenue (ttm) US$ in thousands 4,586,900 4,609,300 4,846,500 5,314,400 5,918,100 6,144,200 5,962,800 5,365,700 4,810,300 4,422,600 4,164,000 3,951,600 4,040,900 4,196,900 4,420,500 4,769,900 4,811,600 4,744,600 4,645,400 4,566,700
Gross profit margin 35.63% 34.06% 33.39% 29.38% 25.94% 21.70% 16.68% 13.30% 11.19% 10.76% 11.12% 11.21% 11.21% 15.98% 20.09% 24.37% 28.51% 28.28% 27.47% 26.58%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,634,200K ÷ $4,586,900K
= 35.63%

The gross profit margin for Carlisle Companies Inc. has seen fluctuations over the past eight quarters. The margin ranged from a low of 29.25% in Q1 2022 to a high of 35.63% in Q4 2023. Overall, the trend shows slight improvements in recent quarters, with the margin peaking in Q4 2023. This indicates that the company has been able to effectively manage its production costs and maintain a higher percentage of revenue as gross profit. The company's ability to consistently improve its gross profit margin suggests efficiency in its operations and pricing strategies, which can positively impact its overall profitability.


Peer comparison

Dec 31, 2023

Company name
Symbol
Gross profit margin
Carlisle Companies Incorporated
CSL
35.63%
West Pharmaceutical Services Inc
WST
38.52%